We are live on
!
Find out more
RCM
Riverhead Capital Management Portfolio holdings
AUM
$2.71B
1-Year Est. Return
2.34%
This Fund
S&P 500
This Quarter
Est. Return
+4.34%
1 Year Est. Return
+2.34%
3 Year Est. Return
+45.7%
5 Year Est. Return
+71.11%
10 Year Est. Return
–
AUM
$1.55B
AUM Growth
-$1.56B
(-50%)
Cap. Flow
-$4.84B
Cap. Flow
% of AUM
-311.51%
Top 10 Holdings %
Top 10 Hldgs %
11.93%
Holding
1,543
New
109
Increased
444
Reduced
906
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$24.3M |
| 2 |
Apple
AAPL
|
+$17.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$16.9M |
| 4 |
AT&T
T
|
+$13.7M |
| 5 |
Merck
MRK
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mid-America Apartment Communities
MAA
|
+$1.33B |
| 2 |
MODV
ModivCare
MODV
|
+$703M |
| 3 |
Prosperity Bancshares
PB
|
+$265M |
| 4 |
MSCC
Microsemi Corp
MSCC
|
+$191M |
| 5 |
VRTU
Virtusa Corporation
VRTU
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.38% |
| 2 | Healthcare | 14.26% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Financials | 11.84% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
1001
Chimera Investment
CIM
$1.04B
| $77K | 0.01% |
+1,600
| New | +$78.3K |
|
1002
NovoCure
NVCR
$1.73B
| $77K | 0.01% |
9,053
+4,301
| +91% | +$39.2K |
|
|
BOBE
1003
DELISTED
Bob Evans Farms, Inc.
BOBE
| $77K | 0.01% |
2,000
-161,284
| -99% | -$6.08M |
|
1004
Molina Healthcare
MOH
$10.2B
| $76K | ﹤0.01% |
1,300
-2,264
| -64% | -$125K |
|
1005
Nektar Therapeutics
NKTR
$2.39B
| $76K | ﹤0.01% |
293
-3,705
| -93% | -$954K |
|
1006
Pembina Pipeline
PBA
$28.4B
| $76K | ﹤0.01% |
2,500
-69,638
| -97% | -$2.1M |
|
1007
Telus
TU
$14.9B
| $76K | ﹤0.01% |
4,600
-20,810
| -82% | -$344K |
|
|
VSTO
1008
DELISTED
Vista Outdoor Inc.
VSTO
| $76K | ﹤0.01% |
1,900
+1,339
| +239% | +$59.1K |
|
1009
Charles River Laboratories
CRL
$11.2B
| $75K | ﹤0.01% |
900
-13,224
| -94% | -$1.11M |
|
1010
Manulife Financial
MFC
$73.9B
| $75K | ﹤0.01% |
5,300
+3,650
| +221% | +$49.6K |
|
1011
Plexus
PLXS
$6.72B
| $75K | ﹤0.01% |
1,600
+874
| +120% | +$40.1K |
|
|
AAT
1012
American Assets Trust
AAT
$1.45B
| $74K | ﹤0.01% |
1,700
-24,403
| -93% | -$1.08M |
|
1013
ACI Worldwide
ACIW
$5.83B
| $74K | ﹤0.01% |
3,800
-1,942
| -34% | -$36.9K |
|
1014
Compass Minerals
CMP
$1.23B
| $74K | ﹤0.01% |
1,000
-1,475
| -60% | -$107K |
|
1015
Commault Systems
CVLT
$4.88B
| $74K | ﹤0.01% |
1,400
-4,837
| -78% | -$243K |
|
1016
Green Dot
GDOT
$743M
| $74K | ﹤0.01% |
3,200
-1,112
| -26% | -$26K |
|
1017
Quaker Houghton
KWR
$2.76B
| $74K | ﹤0.01% |
700
-76,124
| -99% | -$7.43M |
|
1018
Five Below
FIVE
$12B
| $73K | ﹤0.01% |
1,800
-155,093
| -99% | -$7.18M |
|
1019
Neogen
NEOG
$2.63B
| $73K | ﹤0.01% |
3,467
+387
| +13% | +$8.28K |
|
|
CRZO
1020
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $73K | ﹤0.01% |
1,800
-4,965
| -73% | -$178K |
|
1021
Matsons
MATX
$6.13B
| $72K | ﹤0.01% |
1,800
-2,512
| -58% | -$93.1K |
|
1022
LiveRamp
RAMP
$2.3B
| $72K | ﹤0.01% |
2,700
-2,184
| -45% | -$54K |
|
1023
Rayonier
RYN
$6.55B
| $72K | ﹤0.01% |
2,976
+1,157
| +64% | +$28.2K |
|
|
CORE
1024
DELISTED
Core Mark Holding Co., Inc.
CORE
| $72K | ﹤0.01% |
2,000
-5,491
| -73% | -$237K |
|
|
LOGM
1025
DELISTED
LogMein, Inc.
LOGM
| $72K | ﹤0.01% |
800
-8,089
| -91% | -$648K |
|
Similar funds
TAM
TAM
STMM
CC
NA
FCM
CA
BA
Riverhead Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Riverhead Capital Management held 1,543 positions worth $1.55B, down 50% from $3.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Riverhead Capital Management withdrew a net $4.84B in Q3 2016, closing 83 positions and reducing 906 holdings. Its most notable exit was Juno Therapeutics, Inc., an estimated $86.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Riverhead Capital Management opened a new position in LyondellBasell Industries worth $2.28M.
- Riverhead Capital Management's largest Q3 2016 buy was LyondellBasell Industries: 28,311 shares worth $2.28M.
- Riverhead Capital Management added most to Johnson & Johnson in Q3 2016, an estimated $24.3M increase.
- Riverhead Capital Management's biggest Q3 2016 reduction was Mid-America Apartment Communities, cutting an estimated $1.33B.
- Riverhead Capital Management fully exited Juno Therapeutics, Inc. in Q3 2016, selling an estimated $86.8M.
- Riverhead Capital Management's ten largest holdings make up 12% of its $1.55B portfolio in Q3 2016.
- Riverhead Capital Management opened 109 new positions and closed 83 in Q3 2016.
- Riverhead Capital Management's portfolio value fell 50% quarter-over-quarter to $1.55B.
Based on Riverhead Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.